Cipher Pharmaceuticals Inc has seen notable price action this week amidst its recent earnings report.
This week, Cipher Pharmaceuticals Inc (CPH.TO) experienced a significant decline of 18.55% over the past week, despite a modest increase of 1.20% on the last trading day. The recent earnings announcement may have influenced investor sentiment, as the market digests the implications of the company's quarterly performance.
Advertisement
Cipher Pharmaceuticals Inc
CPH.TO
CPH.TO
Cipher Pharmaceuticals Inc
WealthAwesomeMarket cap
$353.68M
P/E
9.1x
52W high
$20.56
52W low
$12.48
1W change
-18.55%
Beta
0.46
Analyst Price Targets
Based on analyst covering CPH
Wall Street analysts forecast CPH stock price to rise 39.4% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$19.95
+39.4% Upside
Current Price
C$14.31
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CPH's historical volatility
30-Day Vol
73.7%
Annualized
90-Day Vol
50.8%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$11.97
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$13.48 | C$10.46 โ C$17.39 |
| 60 trading days | C$12.70 | C$8.87 โ C$18.20 |
| 90 trading days | C$11.97 | C$7.71 โ C$18.59 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should consider the recent earnings report and the stock's technical indicators when evaluating their positions in Cipher Pharmaceuticals. The decline in stock price may present an opportunity for value-focused investors, although the overall market sentiment remains cautious.
Cipher Pharmaceuticals Inc's Stock Declines 18.55% This Week
The stock closed at C$14.31, remaining within 23% of its 52-week range of C$12.48 to C$20.56.
Bull case
Cipher Pharmaceuticals shows strong fundamentals, boasting a profit margin of 60.6% and a return on equity of 25.9%. Analysts have set an average target of C$19.95, suggesting a bullish outlook with a potential upside of 39.4% from the current price.
Bear case
The stock's recent performance has been disappointing, with a year-to-date decline of 3.96% and a notable drop of 18.55% over the last week. Additionally, it is trading well below its 50-day and 200-day moving averages, indicating bearish momentum.
Recent Price Action
Cipher Pharmaceuticals Inc's stock closed at C$14.31, reflecting a modest increase of 1.20% on the last trading day. However, the stock has faced significant pressure recently, with an overall decline of 18.55% over the past week and a 12.74% drop in the last month.
Advertisement
Company News
On August 11, 2026, Cipher Pharmaceuticals reported its second-quarter results. The details of this earnings report could provide insights into the company's operational performance and future outlook, which may have influenced the recent price volatility.
Technical Picture
Currently, Cipher Pharmaceuticals is trading significantly below its 50-day moving average of C$16.53 and its 200-day moving average of C$15.98, indicating bearish momentum. The stock has a beta of 0.46, suggesting lower volatility compared to the broader market. The recent volume of 44,931 shares is approximately 1.74 times the 20-day average volume of 50,511 shares, indicating heightened trading activity.
Insider Activity
No recent insider trading activity has been reported for Cipher Pharmaceuticals, which may suggest a stable insider sentiment during this period of stock volatility.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
